03/31/2025
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/31/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
3:00 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/30/2025
11:40 AM | Galectin Therapeutics (Issuer)
Shlevin Harold H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/28/2025
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/27/2025
3:03 PM | CARSON BENJAMIN SR (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:03 PM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:04 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:05 PM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for GALT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Galectin Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
01/27/2025
3:06 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:06 PM | Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:07 PM | Galectin Therapeutics (Issuer)
Rubin Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:01 PM | Galectin Therapeutics (Issuer)
OMENN GILBERT S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
3:02 PM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/23/2025
10:15 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
6:45 AM | Galectin Therapeutics (Issuer)
Shlevin Harold H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:20 AM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:16 AM | Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:18 AM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:18 AM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:02 AM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
7:07 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:17 PM | CALLICUTT JACK W (Reporting)
Galectin Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
3:18 PM | Galectin Therapeutics (Subject)
LEWIS JOEL (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/23/2024
3:19 PM | Galectin Therapeutics (Subject)
Jamil Khurram (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
7:03 AM | Galectin Therapeutics (Filer)
| Form DEF 14A | |
12/03/2024
7:04 AM | Galectin Therapeutics (Filer)
| Form DEFA14A | |
12/03/2024
7:05 AM | Galectin Therapeutics (Filer)
| Form ARS | |
11/14/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
6:51 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/23/2024
12:39 PM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:12 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:10 PM | Boudes Pol F (Reporting)
Galectin Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/09/2024
7:00 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
7:08 AM | Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad) Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…
To partner with Elon on what he believes will be the biggest AI project of the century…
Starting with as little as $500. Click here to see how you could take a stake in Elon’s private company… |
08/13/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2024
7:41 AM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2024
7:38 AM | Galectin Therapeutics (Issuer)
Jamil Khurram (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/01/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
8:43 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4/A | |
07/23/2024
8:38 AM | ELDRED KARY (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
12:55 PM | FREEMAN KEVIN D (Reporting)
Galectin Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
6:50 AM | Galectin Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024
6:55 AM | Galectin Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
1:14 PM | Galectin Therapeutics (Issuer)
Zordani Richard A. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
12:27 PM | Galectin Therapeutics (Issuer)
LEWIS JOEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2024
10:37 AM | CZIRR JAMES C (Reporting)
Galectin Therapeutics (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
